Home › Funds › Cutter & CO Brokerage, Inc. › VRTX

Cutter & CO Brokerage, Inc. position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Cutter & CO Brokerage, Inc. reported holding 8,407 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q1 2025 13F filing — a position valued at US$4.1M, representing 0.96% of its reported portfolio and ranking #27 among its reported holdings. Cutter & CO Brokerage, Inc. has disclosed VRTX holdings in 7 of the last 7 reported quarters, going back to Q3 2023.

Latest position (Q1 2025)8.41K sh
Reported value held$4.08M
Portfolio Weight0.96%
First reportedQ3 2023
Last changeReduce
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Cutter & CO Brokerage, Inc.'s VRTX position evolved

Cutter & CO Brokerage, Inc. first disclosed a stake in VRTX in Q3 2023 at 12,001 shares (US$4.2M). The position peaked in Q2 2024 at 11,734 shares, worth US$5.5M. Across 7 filings, Cutter & CO Brokerage, Inc. increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2025) shows 8,407 shares valued at US$4.1M — a reduction of -3,355 shares quarter over quarter.. Notable position changes include a 29% trim in Q1 2025 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.00K $4.17M New
Q4 2023 11.79K $4.80M Reduce
Q1 2024 11.91K $4.98M Add
Q2 2024 11.73K $5.50M Reduce
Q3 2024 11.54K $5.37M Reduce
Q4 2024 11.76K $4.74M Add
Q1 2025 8.41K $4.08M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Cutter & CO Brokerage, Inc. held VRTX?

Cutter & CO Brokerage, Inc. has disclosed VRTX holdings in 7 of the last 7 reported quarters, going back to Q3 2023.

What is Cutter & CO Brokerage, Inc.'s current position in VRTX?

As of Q1 2025, Cutter & CO Brokerage, Inc. holds 8.41K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $4.08M, representing 0.96% of its reported portfolio and ranking #27.

Has Cutter & CO Brokerage, Inc. been buying or selling VRTX?

In the latest 13F filing (Q1 2025), Cutter & CO Brokerage, Inc. reduced its position in VRTX. The position peaked in Q2 2024 at 11.73K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.